[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cronos Group Inc (CRON)

Cronos Group Inc (CRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cronos Group Inc 4491 CONCESSION RD 12 STAYNER A6 L0M 1S0 CAN

www.thecronosgroup.com Employees: 610 P: 416-504-0004

Sector:

Medical

Description:

Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as PharmaCan Capital Corp., is headquartered in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 1,042,271
Enterprise Value, $K 250,481
Shares Outstanding, K 376,271
Float, K 346,922
% Float 92.20%
Short Interest, K 4,558
Short Float 1.21%
Days to Cover 5.27
Short Volume Ratio 0.32
% of Insider Shareholders 7.80%
% of Institutional Shareholders 8.71%

Financials:

Annual Sales, $ 146,590 K
Annual Net Income, $ -9,450 K
Last Quarter Sales, $ 44,530 K
Last Quarter Net Income, $ -1,820 K
EBIT, $ -14,430 K
EBITDA, $ -200 K

Growth:

1-Year Return 33.82%
3-Year Return 42.93%
5-Year Return -63.01%
5-Year Revenue Growth 213.76%
5-Year Earnings Growth 94.74%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 02/26/26
Next Earnings Date 08/06/26
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Year -50.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CRON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 34.38
Price/Earnings to Growth N/A
Return-on-Equity % -1.41%
Return-on-Assets % -1.35%
Profit Margin % -6.45%
Debt/Equity 0.00
Price/Sales 7.06
Price/Cash Flow 219.35
Price/Book 0.92
Book Value/Share 3.00
Interest Coverage -0.77
60-Month Beta 0.87
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.